Ironwood Pharmaceuticals to Participate in Upcoming September Investor Conferences
https://investor.ironwoodpharma.com/press-releases/press-release-details/2021/Ironwood-Pharmaceuticals-to-Participate-in-Upcoming-September-Investor-Conferences/default.aspx
Ironwood Pharmaceuticals Announces FDA Approval of Revised LINZESS® (linaclotide) Label
https://investor.ironwoodpharma.com/press-releases/press-release-details/2021/Ironwood-Pharmaceuticals-Announces-FDA-Approval-of-Revised-LINZESS-linaclotide-Label/default.aspx
Ironwood Pharmaceuticals Announces FDA Approval of Revised LINZESS® (linaclotide) Label
https://investor.ironwoodpharma.com/press-releases/press-release-details/2021/Ironwood-Pharmaceuticals-Announces-FDA-Approval-of-Revised-LINZESS-linaclotide-Label/default.aspx
Ironwood Pharmaceuticals Reports Strong Second-Quarter 2021 Results, Raises Full-Year Guidance
https://investor.ironwoodpharma.com/press-releases/press-release-details/2021/Ironwood-Pharmaceuticals-Reports-Strong-Second-Quarter-2021-Results-Raises-Full-Year-Guidance/default.aspx
Ironwood Pharmaceuticals Reports Strong Second-Quarter 2021 Results, Raises Full-Year Guidance
https://investor.ironwoodpharma.com/press-releases/press-release-details/2021/Ironwood-Pharmaceuticals-Reports-Strong-Second-Quarter-2021-Results-Raises-Full-Year-Guidance/default.aspx
Ironwood Pharmaceuticals Appoints John Minardo as Chief Legal Officer
https://investor.ironwoodpharma.com/press-releases/press-release-details/2021/Ironwood-Pharmaceuticals-Appoints-John-Minardo-as-Chief-Legal-Officer/default.aspx
Ironwood Pharmaceuticals Appoints John Minardo as Chief Legal Officer
https://investor.ironwoodpharma.com/press-releases/press-release-details/2021/Ironwood-Pharmaceuticals-Appoints-John-Minardo-as-Chief-Legal-Officer/default.aspx
Ironwood Pharmaceuticals to Host Second Quarter 2021 Investor Update Call
https://investor.ironwoodpharma.com/press-releases/press-release-details/2021/Ironwood-Pharmaceuticals-to-Host-Second-Quarter-2021-Investor-Update-Call/default.aspx
Ironwood Pharmaceuticals to Host Second Quarter 2021 Investor Update Call
https://investor.ironwoodpharma.com/press-releases/press-release-details/2021/Ironwood-Pharmaceuticals-to-Host-Second-Quarter-2021-Investor-Update-Call/default.aspx
Ironwood Pharmaceuticals Announces That The American Journal of Gastroenterology Publishes Full Results from Positive LINZESS® (linaclotide) Phase IIIb Trial in Adults with Irritable Bowel Syndrome with Constipation (IBS-C)
https://investor.ironwoodpharma.com/press-releases/press-release-details/2021/Ironwood-Pharmaceuticals-Announces-That-The-American-Journal-of-Gastroenterology-Publishes-Full-Results-from-Positive-LINZESS-linaclotide-Phase-IIIb-Trial-in-Adults-with-Irritable-Bowel-Syndrome-with-Constipation-IBS-C/default.aspx